Table 4 |
||
|
Scores of prescribing quality indicators identified with different approaches |
||
|
Prescribing quality indicators (PQI) |
Outcome of the PQI, %, (95% CI) numerator/denominator |
|
|
Diagnostic code-based |
Measurement-based |
|
|
|
||
|
PQI-1 Prescription of any antihypertensive medication in hypertensive T2DM patients |
93(90-95) 1412/1749 |
81 (78-83) 905/984 |
|
|
||
|
PQI-2 Prescription of beta blocker in hypertensive T2DM patients with a history of IHD or MI |
65(57-72) 100/155 |
64 (56-72) 125/194 |
|
|
||
|
PQI-3 Prescription of metformin in overweight T2DM patients |
65(59-72) 39/213 |
66(62-69) 1154/1767 |
|
|
||
|
T2DM: Type 2 Diabetes mellitus IHD: Ischaemic Heart Disease MI: Myocardial Infarction |
||
|
Martirosyan et al. BMC Health Services Research 2010 10:137 doi:10.1186/1472-6963-10-137 |
||
